Mitchell Warren
Latest Articles
Opinion: The US legacy in HIV is unraveling
9 months ago // Global Health
With PEPFAR facing precarious uncertainty, shifting priorities and dwindling expertise raise alarms. Will the U.S. Congress intervene?
Opinion: The world has a new HIV prevention drug. Let’s use it
about 1 year ago // Global Health
There is hope for a new 5 by 3 global target of getting 5 million people on long-acting PrEP to prevent HIV by 2030.
Opinion: US leadership matters in fighting AIDS
over 4 years ago // PEPFAR
The failure to appoint a leader for the U.S. President's Emergency Plan for AIDS Relief sends the message that HIV is no longer a priority for the U.S. administration.
Opinion: Why exciting results from vaccine research are just the beginning of efforts to end COVID-19
over 5 years ago // COVID-19
Decades of research and advocacy that led to achievements in HIV provide important lessons for the global responses to COVID-19.
Opinion: To accelerate search for COVID-19 vaccine, look to HIV and act globally
almost 6 years ago // COVID-19
Looking back at over 40 years of experience in the HIV response, this op-ed explores what is needed for the containment of a health crisis — and for vaccine success.
Opinion: We won't meet the 2020 AIDS targets. Now what?
over 6 years ago // HIV/AIDS
It is time to redouble efforts and investments in HIV prevention. In this opinion piece, AVAC Executive Director Mitchell Warren celebrates 2020 as the year of diverse, brave, activist leadership in HIV — from the grassroots to Geneva — and takes a look at its impact.